A Type II Segmental Vitiligo Developed under Infliximab Treatment for Ulcerative Colitis

被引:8
作者
Ryu, Tae Hyung [1 ]
Lee, Dong Won [1 ]
Choi, Jae Eun [1 ]
Ahn, Hyo Hyun [1 ]
Kye, Young Chul [1 ]
Seo, Soo Hong [1 ]
机构
[1] Korea Univ, Coll Med, Dept Dermatol, Seoul, South Korea
关键词
DISEASE;
D O I
10.5021/ad.2017.29.6.826
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:826 / 827
页数:2
相关论文
共 5 条
[1]   Infliximab-induced vitiligo [J].
Ramírez-Hernández, M ;
Marras, C ;
Martínez-Escribano, JA .
DERMATOLOGY, 2005, 210 (01) :79-80
[2]  
SNOOK JA, 1989, Q J MED, V72, P835
[3]  
Song Min-Seok, 1994, Annals of Dermatology, V6, P22
[4]   Paradoxical reactions under TNF-alpha blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview [J].
Toussirot, Eric ;
Aubin, Francois .
RMD OPEN, 2016, 2 (02)
[5]   Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo [J].
Webb, K. C. ;
Tung, R. ;
Winterfield, L. S. ;
Gottlieb, A. B. ;
Eby, J. M. ;
Henning, S. W. ;
Le Poole, I. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (03) :641-650